At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 124 enrolled
Drug / intervention
Plecanatide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Placebo-controlled, 3 Dose Level, Parallel Group Study of the Efficacy and Safety of Plecanatide in Adolescents 12 to < 18 Years of Age With Chronic Idiopathic Constipation (CIC)
In Brief
A Phase 2 clinical trial evaluating Plecanatide and Matching placebo for Chronic Idiopathic Constipation. Completed, enrolled 124 participants across 36 sites.
Detailed Summary
This is a study of efficacy and safety of Plecanatide in pediatric subjects aged 12 to \< 18 years diagnosed with Chronic Idiopathic Constipation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Idiopathic Constipation
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJan 2017
First PostedApr 2017
Primary CompletionSep 2018
TodayJul 2026
First PostedApr 19, 2017
Enrollment StartJan 1, 2017
Primary CompletionSep 7, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.2 years ago
Interventions
Plecanatidedrug
Matching placebodrug